Skip to main content

Cristina Hernández Pascual

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Cristina Hernández Pascual

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) Grant Agreement nº 278040

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: EUROPEAN COMMISSION
Funding: 936725.31
Reference: EUROCONDOR_FP7HEALTH2011/VHIR
Duration: 01/03/2012 - 30/06/2016

Neurodegeneration as an early event in the pathogenesis of diabetic netinopathy. Study of involved mechanisms and new therapeutic strategies

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Patricia Bogdanov Baruj
Funding agency: European Foundation for the Study of Diabetes
Funding: 100000
Reference: EFSD-2010-02
Duration: 28/10/2010 - 27/04/2012

Grup de Recerca en Diabetis i Metabolisme

IP: Rafael Simó Canonge
Collaborators: Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Andreea Ciudin Mihai
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 739
Duration: 01/01/2010 - 30/04/2014

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: David Martinez Selva
Collaborators: Rafael Simó Canonge, Cristina Hernández Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 42000
Reference: CP08/00058
Duration: 01/01/2009 - 31/12/2011

Related news

The study evaluates elecoglipron and shows improvements in glycemic control and body weight compared with placebo.

The study is expected to contribute to the identification of new therapeutic targets and the development of nutritional strategies to improve health.

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

Related professionals

Neus Grau Novellas

Neus Grau Novellas

Tècnic de recerca
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
José Antonio Arranz  Amo

José Antonio Arranz Amo

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Julia Sanchon Soler

Julia Sanchon Soler

Gestió i Administració
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more
Cora Oliver Vila

Cora Oliver Vila

Research technician
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.